Authors
Latest:
Designing Well-Being Intervention Trials for People With Progressive Multiple Sclerosis: The Importance of Understanding Usual Care ComparatorsFor a clinical audience, our team’s efforts highlight that usual care looks different across clinics, regions, and countries, which highlights the importance of interpreting the results of trials with usual care comparators carefully.
Latest:
Symptoms as Correlates of Health-Related Quality of Life in Black and White Individuals With Multiple SclerosisThe management of walking impairment and fatigue may be appropriate for improving physical health-related quality of life among Black and White people with multiple sclerosis.
Latest:
Multiple Sclerosis in the Middle East and North Africa: Perspectives and ChallengesThe prevalence of multiple sclerosis is increasing in the Middle East and North Africa (MENA), in part due to better access to earlier diagnosis. Many MENA countries are now considered to fall in moderate to high MS risk zones.
Latest:
Ofatumumab Interruption Results in Disease Reactivation: A Case ReportAlthough intravenous anti-CD20 therapies have shown benefits beyond their standard dosing schedule, the long-term effects of ofatumumab, an anti-CD20 therapy with a shorter half-life, are less understood.
Latest:
Outcomes of Comprehensive Multiple Sclerosis Care: A Pilot Comparison of Intensive, Integrated, and Usual Care ApproachesA short, intense, comprehensive program can provide education and training that can lead to more confidence in disease management for people with multiple sclerosis.